Automated 3D organoid screening technology

Proprietary patented technology to integrate and scale standard 2D assays to 3D organoid on chip, elevating your discovery workflow

Okomera's CTO using the machine in the laboratory

High-throughput

+1000 organoids per run

Miniaturized

Only 50 cells to generate an organoid

Multiplexing

+100 conditions per run

Co-culture

+3 cell types

AI readout

End to end AI analysis platform

Explore the future of drug discovery. Start today!

Our Partners